- Home
- BOLT vs PAVM Comparison
BOLT vs PAVM Comparison
Compare BOLT & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- PAVM
- Stock Information
- Founded
- BOLT 2015
- PAVM 2014
- Country
- BOLT United States
- PAVM United States
- Employees
- BOLT N/A
- PAVM N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- BOLT Health Care
- PAVM Health Care
- Exchange
- BOLT Nasdaq
- PAVM Nasdaq
- Market Cap
- BOLT 11.5M
- PAVM 9.3M
- IPO Year
- BOLT 2021
- PAVM 2016
- Fundamental
- Price
- BOLT $5.05
- PAVM $0.36
- Analyst Decision
- BOLT Buy
- PAVM Strong Buy
- Analyst Count
- BOLT 4
- PAVM 1
- Target Price
- BOLT $34.00
- PAVM $20.00
- AVG Volume (30 Days)
- BOLT 34.2K
- PAVM 569.3K
- Earning Date
- BOLT 11-12-2025
- PAVM 11-13-2025
- Dividend Yield
- BOLT N/A
- PAVM N/A
- EPS Growth
- BOLT N/A
- PAVM N/A
- EPS
- BOLT N/A
- PAVM N/A
- Revenue
- BOLT $5,195,000.00
- PAVM $29,000.00
- Revenue This Year
- BOLT N/A
- PAVM N/A
- Revenue Next Year
- BOLT N/A
- PAVM $234.47
- P/E Ratio
- BOLT N/A
- PAVM N/A
- Revenue Growth
- BOLT N/A
- PAVM N/A
- 52 Week Low
- BOLT $4.41
- PAVM $0.30
- 52 Week High
- BOLT $13.00
- PAVM $1.25
- Technical
- Relative Strength Index (RSI)
- BOLT 50.64
- PAVM 47.68
- Support Level
- BOLT $4.66
- PAVM $0.31
- Resistance Level
- BOLT $5.14
- PAVM $0.40
- Average True Range (ATR)
- BOLT 0.28
- PAVM 0.04
- MACD
- BOLT 0.06
- PAVM 0.00
- Stochastic Oscillator
- BOLT 93.15
- PAVM 43.75
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.